Maternal Iodine Status During Pregnancy Is Not Consistently Associated with Attention-Deficit Hyperactivity Disorder or Autistic Traits in Children

Authors:

Abstract
Background: Severe iodine deficiency during pregnancy can cause intellectual disability, presumably through inadequate placental transfer of maternal thyroid hormone to the fetus. The association between mild-to-moderate iodine deficiency and child neurodevelopmental problems is not well understood. Objectives: We investigated the association of maternal iodine status during pregnancy with child attention-deficit hyperactivity disorder (ADHD) and autistic traits. Methods: This was a collaborative study of 3 population-based birth cohorts: Generation R (n = 1634), INfancia y Medio Ambiente (n = 1293), and the Avon Longitudinal Study of Parents and Children (n = 2619). Exclusion criteria were multiple fetuses, fertility treatment, thyroid-interfering medication use, and pre-existing thyroid disease. The mean age of assessment in the cohorts was between 4.4 and 7.7 y for ADHD symptoms and 4.5 and 7.6 y for autistic traits. We studied the association of the urinary iodine-to-creatinine ratio (UI/Creat) = 93rd percentile cutoff), using logistic regression. The cohort-specific effect estimates were combined by random-effects meta-analyses. We also investigated whether UI/Creat modified the associations of maternal free thyroxine (FT4) or thyroid-stimulating hormone concentrations with ADHD or autistic traits. Results: UI/Creat <150 mu g/g was not associated with ADHD (OR: 1.2; 95% CI: 0.7, 2.2; P = 0.56) or with a high autistic-trait score (OR: 0.8; 95% CI: 0.6, 1.1; P = 0.22). UI/Creat <150 mu g/g in early pregnancy (i.e., <= 18 weeks or <= 14 weeks of gestation) was not associated with a higher risk of behavioral problems. The association between a higher FT4 and a greater risk of ADHD (OR: 1.3; 95% CI: 1.0, 1.6; P = 0.017) was not modified by iodine status. Conclusions: There is no consistent evidence to support an association of mild-to-moderate iodine deficiency during pregnancy with child ADHD or autistic traits.
Funding Information
  • European Union's Horizon 2020 (634453)
  • Sophia Children's Hospital Research Funds
  • ZonMw VIDI (1717331)
  • ZonMW VICI (016.VICI.170.200)
  • UE (FP7-ENV-2011)
  • Instituto de Salud Carlos III (INMA G03/176, CB06/02/0041, PI041436, PI05/1079, PI06/0867, PI081151, PI09/00090, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, CP11/00178, CP15/00025, CPII16/00051, MS13/00054, MS15/0025, MSII16/0051)
  • Alicia Koplowitz Foundation
  • FISABIO (UGP-15-230, UGP-15-244, UGP-15-249)
  • Generalitat de Catalunya-CIRIT (1999SGR 00241)
  • Fundació la Marató de TV3 (090430)
  • Department of Health of the Basque Government (2005111093, 2009111069)
  • Provincial Government of Gipuzkoa (DFG06/004, DFG08/001)
  • UK Medical Research Council
  • Wellcome Trust (102215/2/13/2)
  • University of Bristol
  • European Community's 7th Framework Programme (FP7/2008–2013, 212652)
  • Wassen International
  • Waterloo Foundation

This publication has 79 references indexed in Scilit: